BMJ1d
POS1328 DIFFERENTIATING “SCLERODERMA” WITH “NON-SCLERODERMA” PATTERNS IN NAILFOLD CAPILLARY MICROSCOPY USING A DEEP LEARNING MODEL
Background Nailfold capillary microscopy is used for diagnostic purposes in rheumatology since many years. Abnormal nailfold capillaries are also listed in the 2013 ACR/EULAR classification criteria ...
BMJ1d
POS0835 EFFECTIVENESS AND SAFETY OF JAK INHIBITORS IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 57 PATIENTS
1 Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Division of Rheumatology, Santander, Spain 2 Hospital Universitario Donostia, Division of Rheumatology, Donostia, Spain 3 Hospital de ...
BMJ1d
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Correspondence to Dr Antonis Fanouriakis, Rheumatology and Clinical Immunology Unit, “Attikon” University Hospital, Athens 12462, Greece; afanour{at}med.uoa.gr Our objective was to update the EULAR ...
BMJ1d
TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis
Objective Innate lymphoid cells-2 (ILC2) were shown to be involved in the development of lung or hepatic fibrosis. We sought to explore the functional and phenotypic heterogeneity of ILC2 in skin ...
BMJ2d
SAT0073 MIR-186-5P targeting IL-33 gene as biomarker to predict subclinical atherosclerosis in patients with early rheumatoid arthritis
Background Patients with rheumatoid arthritis (RA) die prematurely compared with the general population, primarily because of cardiovascular diseases (CVD). Interleukin-33 (IL-33) is a member of the ...
BMJ2d
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation
Correspondence to Dr Laura C Cappelli, Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD 21224, USA; lcappel1{at}jhmi.edu Objective We sought to investigate the long-term outcomes of ...
BMJ2d
EULAR definition of difficult-to-treat rheumatoid arthritis
Background Despite treatment according to the current management recommendations, a significant proportion of patients with rheumatoid arthritis (RA) remain symptomatic. These patients can be ...
BMJ3d
OP0157 CCL2-CCR2 AXIS MEDIATES DECIDUAL MONOCYTE/MACROPHAGE INFILTRATION AND INFLAMMATION IN OBSTETRIC ANTIPHOSPHOLIPID SYNDROME
1 West China Second University Hospital, Sichuan University, The Reproductive Medical Center, Department of Obstetrics and Gynecology, Chengdu, China 2 The Third Affiliated Hospital of Sun Yet-Sen ...
BMJ5d
Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities
Only a minority of patients with eosinophilic granulomatosis with polyangiitis (EGPA) can be weaned-off glucocorticoids (GC) using conventional treatment strategies. The development of biological ...
BMJ5d
AB1006 PULMONARY MANIFESTATIONS OF AXIAL SPONDYLOARTHRITIS (AXSPA): A SYSTEMATIC LITERATURE REVIEW
Background Common extra musculoskeletal manifestations (EMM) of axSpA include uveitis, inflammatory bowel disease, and psoriasis; and some of the uncommon manifestations include aortic incompetence, ...
BMJ5d
Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein
2 Department of Orthopaedic Surgery (RKU), University of Ulm, Germany 3 Department of Internal Medicine II—Cardiology, University of Ulm, Germany Correspondence to: Dr T Stürmer Department of ...
BMJ6d
Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus
Correspondence to Dr Keishi Fujio, Department of Allergy and Rheumatology, The University of Tokyo, Bunkyo-ku, Tokyo, Japan; fujiok-int{at}h.u-tokyo.ac.jp; Dr Yukiko Iwasaki, Department of Palliative ...